Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H24O2 |
Molecular Weight | 284.3927 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@](C)(O)[C@@]1(C)C=CC3=C4CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=CCCIJQPRIXGQOE-XWSJACJDSA-N
InChI=1S/C19H24O2/c1-18-9-7-15-14-6-4-13(20)11-12(14)3-5-16(15)17(18)8-10-19(18,2)21/h7,9,11,16-17,21H,3-6,8,10H2,1-2H3/t16-,17+,18+,19+/m1/s1
Metribolone, also known as methyltrienolone, an anabolic agent, binds to the androgen receptor and was studied for the treatment of advanced breast cancer. However, because of the liver toxicity, further development of this drug was discontinued. Now, this compound is used for research purpose as synthetic androgen.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Topographic recognition of cyclic hydrocarbons and related compounds by receptors for androgens, estrogens, and glucocorticoids. | 1987 |
|
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action. | 2006 Aug |
|
p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line. | 2006 Dec 31 |
|
Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. | 2007 Apr |
|
Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer. | 2007 Apr 1 |
|
17beta-Estradiol differentially regulates androgen-responsive genes through estrogen receptor-beta- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells. | 2007 Feb |
|
The synthetic androgen methyltrienolone (r1881) acts as a potent antagonist of the mineralocorticoid receptor. | 2007 Feb |
|
Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. | 2007 Jan |
|
Evaluation of an in vitro model of androgen ablation and identification of the androgen responsive proteome in LNCaP cells. | 2007 Jan |
|
Testosterone and progesterone rapidly attenuate plasma membrane Gbetagamma-mediated signaling in Xenopus laevis oocytes by signaling through classical steroid receptors. | 2007 Jan |
|
Differential regulation of clusterin and its isoforms by androgens in prostate cells. | 2007 Jan 26 |
|
Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP. | 2007 Jun |
|
Labeling and identification of LNCaP cell surface proteins: a pilot study. | 2007 Jun 15 |
|
Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. | 2007 Jun 29 |
|
Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP. | 2007 Mar |
|
Ligand-specific dynamics of the androgen receptor at its response element in living cells. | 2007 Mar |
|
Rapid, non-destructive, cell-based screening assays for agents that modulate growth, death, and androgen receptor activation in prostate cancer cells. | 2007 Mar 1 |
|
Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells. | 2007 May |
|
The role of androgen in determining differentiation and regulation of androgen receptor expression in the human prostatic epithelium transient amplifying population. | 2007 Sep |
|
Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer. | 2007 Sep 1 |
|
Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer. | 2007 Sep 15 |
|
Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism. | 2008 Apr |
|
Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. | 2008 Nov-Dec |
|
Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. | 2008 Oct |
|
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer. | 2008 Oct 1 |
|
A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice. | 2008 Oct 15 |
|
Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. | 2009 Apr 1 |
|
Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells. | 2009 Aug 1 |
|
Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic. | 2009 Mar |
|
Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter. | 2009 Nov 13 |
|
Cumulative and antagonistic effects of a mixture of the antiandrogens vinclozolin and iprodione in the pubertal male rat. | 2009 Sep |
|
Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. | 2009 Sep 10 |
|
Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer. | 2010 Aug 11 |
|
Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP. | 2011 Feb |
|
Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. | 2011 Jun 15 |
|
Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291. | 2011 Sep |
|
Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells. | 2012 |
|
The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer. | 2012 |
|
Anti-androgen effects of cypermethrin on the amino- and carboxyl-terminal interaction of the androgen receptor. | 2012 Feb 26 |
|
Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation. | 2013 |
|
Ligand-independent androgen receptor antagonism caused by the newly developed pesticide pyrifluquinazon (PFQ). | 2013 Jan |
|
Bisphenol A affects androgen receptor function via multiple mechanisms. | 2013 May 25 |
|
Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. | 2013 Oct |
|
Simultaneous determination of the UV-filters benzyl salicylate, phenyl salicylate, octyl salicylate, homosalate, 3-(4-methylbenzylidene) camphor and 3-benzylidene camphor in human placental tissue by LC-MS/MS. Assessment of their in vitro endocrine activity. | 2013 Oct 1 |
|
Currently used pesticides and their mixtures affect the function of sex hormone receptors and aromatase enzyme activity. | 2013 Oct 15 |
|
Copper signaling axis as a target for prostate cancer therapeutics. | 2014 Oct 15 |
|
Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach. | 2015 Dec 15 |
|
p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines. | 2015 Mar 25 |
|
LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer. | 2015 Oct 6 |
|
The Flame-Retardant Tris(1,3-dichloro-2-propyl) Phosphate Represses Androgen Signaling in Human Prostate Cancer Cell Lines. | 2016 May |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
4000
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
||
|
WIKIPEDIA |
Designer-drugs-Metribolone
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
965-93-5
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
2180
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
METRIBOLONE
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
C166564
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
261000
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
2C323EGI97
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
379896
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
DB02998
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
SUB08918MIG
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
DTXSID8034162
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
92858
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
m7473
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL166444
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY | |||
|
100000080945
Created by
admin on Sat Dec 16 16:54:55 GMT 2023 , Edited by admin on Sat Dec 16 16:54:55 GMT 2023
|
PRIMARY |
ACTIVE MOIETY